Spots Global Cancer Trial Database for vestibular schwannoma
Every month we try and update this database with for vestibular schwannoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients | NCT01222728 | Neoplasms Nervous System ... Vestibular Dise... | 18 Years - 50 Years | National Institutes of Health Clinical Center (CC) | ||
| Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma | NCT04859335 | Vestibular Schw... | gammaknife radi... | 18 Years - 65 Years | University Hospital, Toulouse | |
| Preoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma Surgery | NCT02275325 | Vestibular Schw... | Preoperative ve... | 18 Years - 75 Years | Central Hospital, Nancy, France | |
| Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery | NCT05567341 | Vestibular Schw... | Remote ischemic... Sham-control | 18 Years - | University Hospital Tuebingen | |
| Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI | NCT03593577 | Vestibular Schw... | 18 Years - | University Hospital, Strasbourg, France | ||
| Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) | NCT04374305 | Neurofibromatos... Vestibular Schw... Non-vestibular ... Meningioma Ependymoma | Brigatinib Neratinib | 12 Years - | Massachusetts General Hospital | |
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital | |
| StableEyes With Active Neurofeedback | NCT05622344 | Vestibular Diso... Vestibular Schw... Space Motion Si... Motion Sickness | Traditional The... SWAN | 21 Years - 70 Years | Johns Hopkins University | |
| Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging | NCT03097822 | Vestibular Schw... | 20 Years - | Seoul National University Hospital | ||
| Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma | NCT02282917 | Vestibular Schw... Meningioma Acoustic Neurom... Neurofibromatos... | AR-42 | 18 Years - | Massachusetts Eye and Ear Infirmary | |
| Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma | NCT03958006 | Vestibular Schw... Cochlear Implan... | Cochlear implan... | 18 Years - 99 Years | Ascension South East Michigan | |
| Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach | NCT02309099 | Unilateral Acou... Meniere's Disea... | Cochlear Implan... | 18 Years - 99 Years | University of North Carolina, Chapel Hill | |
| Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma | NCT05641441 | Vestibular Schw... Ototoxicity | Stereotactic ra... | 18 Years - | University Hospital, Geneva | |
| Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients | NCT01490476 | Neurofibromatos... | RAD001 | 15 Years - | Assistance Publique - Hôpitaux de Paris | |
| Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma | NCT03958006 | Vestibular Schw... Cochlear Implan... | Cochlear implan... | 18 Years - 99 Years | Ascension South East Michigan | |
| Intraoperative EABR for Decision Making | NCT03745560 | Vestibular Schw... Hearing Loss | 18 Years - 99 Years | Medical University of Vienna | ||
| Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma | NCT04859335 | Vestibular Schw... | gammaknife radi... | 18 Years - 65 Years | University Hospital, Toulouse | |
| Vestibular Schwannoma - Radiosurgery or Expectation: V-REX. | NCT02249572 | Vestibular Schw... | gamma knife rad... | 18 Years - 70 Years | Haukeland University Hospital | |
| Preoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma Surgery | NCT02275325 | Vestibular Schw... | Preoperative ve... | 18 Years - 75 Years | Central Hospital, Nancy, France | |
| Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery | NCT06112509 | Vestibular Schw... Neurinoma, Acou... Acoustic Neurom... | Vestibular exam | 18 Years - 90 Years | Centre Hospitalier Universitaire de Besancon | |
| Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function | NCT02415257 | Vestibular Schw... | Gentamicin | 18 Years - | Lund University | |
| Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma | NCT02963896 | Vestibular Schw... | gentamicin | - | University Hospital, Motol | |
| Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma | NCT01199978 | Vestibular Schw... Acoustic Neurom... | Fractionated pr... Losartan | 18 Years - | Massachusetts General Hospital | |
| Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma | NCT05116878 | Vestibular Schw... | Omega-3 Placebo | 18 Years - | Mayo Clinic | |
| Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging | NCT03097822 | Vestibular Schw... | 20 Years - | Seoul National University Hospital | ||
| Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | NCT02104323 | Vestibular Schw... Neurofibromatos... | Endostatin | 16 Years - 30 Years | Beijing Tiantan Hospital | |
| Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma Surgery | NCT05248113 | Deafness | Electrical stim... | 18 Years - 99 Years | University of California, Irvine | |
| Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy | NCT04594057 | Vestibular Schw... Vestibular Diso... | Gaze and Postur... | 18 Years - 85 Years | University of Utah | |
| Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma | NCT02963896 | Vestibular Schw... | gentamicin | - | University Hospital, Motol | |
| Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging | NCT03097822 | Vestibular Schw... | 20 Years - | Seoul National University Hospital | ||
| Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach | NCT02309099 | Unilateral Acou... Meniere's Disea... | Cochlear Implan... | 18 Years - 99 Years | University of North Carolina, Chapel Hill | |
| Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma | NCT01345136 | Neurofibromatos... Neuroma, Acoust... | RAD001, everoli... | 16 Years - 65 Years | Jonsson Comprehensive Cancer Center | |
| Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma | NCT01083966 | Vestibular Schw... | Bevacizumab (Av... | 18 Years - | Northwell Health | |
| Consequence of Unilateral Vestibular Loss on Visual Abilities | NCT03581331 | Vestibular Schw... Visual Impairme... Vestibular Meni... | orthoptic balan... | 18 Years - 80 Years | Assistance Publique Hopitaux De Marseille | |
| Natural History Study of Patients With Neurofibromatosis Type 2 | NCT00598351 | Neurofibromatos... | 8 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Protocol for Evaluating a Planning Algorithm for Gamma Knife Radiosurgery | NCT03520829 | Vestibular Schw... Brain Metastase... Para-optic Meni... | Intuitive Plan | 18 Years - | Assistance Publique Hopitaux De Marseille | |
| Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma | NCT04196933 | Migraine Vestibular Migr... Vestibular Schw... Motion Sickness Dizziness Vestibular Diso... | Temporal Bindin... Temporal Bindin... Temporal Bindin... Chronic Motion-... | 8 Years - 80 Years | Massachusetts Eye and Ear Infirmary | |
| Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | NCT02934256 | Vestibular Schw... Neurofibromatos... | Icotinib | 16 Years - 50 Years | Beijing Tiantan Hospital | |
| Vestibular Evaluation After Vestibular Schwannoma Treatment | NCT03670589 | Dizziness | Radiosurgery ga... Microsurgery re... | 18 Years - | University Hospital, Grenoble | |
| Role of ChatGPT in Vestibular Schwannoma Management | NCT06163664 | Vestibular Schw... | Use of chatGPT ... | 18 Years - | University of Southern California | |
| Protocol for Evaluating a Planning Algorithm for Gamma Knife Radiosurgery | NCT03520829 | Vestibular Schw... Brain Metastase... Para-optic Meni... | Intuitive Plan | 18 Years - | Assistance Publique Hopitaux De Marseille | |
| Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | NCT00973739 | Neurofibromatos... Vestibular Schw... | Lapatinib | 4 Years - 80 Years | NYU Langone Health | |
| Vegetative Monitoring During Brainstem-associated Surgery | NCT03666507 | Brain Tumor, Re... Vestibular Schw... Brainstem Neopl... Brainstem Gliom... | Intraoperative ... | - | University Hospital Tuebingen | |
| Study of Aspirin in Patients With Vestibular Schwannoma | NCT03079999 | Vestibular Schw... Acoustic Neurom... Neurofibromatos... | Aspirin Placebo | 12 Years - | Massachusetts Eye and Ear Infirmary | |
| Vestibular Evaluation After Vestibular Schwannoma Treatment | NCT03670589 | Dizziness | Radiosurgery ga... Microsurgery re... | 18 Years - | University Hospital, Grenoble | |
| Novel Multimodality Imaging for Navigation in Skull Base Surgery | NCT04128345 | Vestibular Schw... | Use of navigati... | 18 Years - 85 Years | University College, London | |
| Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery | NCT00438087 | Facial Palsy | methylprednisol... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors | NCT03095248 | Neurofibromatos... Vestibular Schw... Meningioma Ependymoma Glioma | Selumetinib | 3 Years - 45 Years | Children's Hospital Medical Center, Cincinnati | |
| Vestibular Outcomes in Vestibular Schwannoma | NCT03346889 | Vestibular Schw... | - | Haukeland University Hospital | ||
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital | |
| Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas | NCT05702749 | Vestibular Schw... | Microsurgical r... Stereotactic ra... PREHAB | 18 Years - | Medical College of Wisconsin | |
| Vestibular Schwannoma Organoids | NCT05786144 | Vestibular Schw... | 18 Years - | Maastricht Radiation Oncology | ||
| StableEyes With Active Neurofeedback | NCT05622344 | Vestibular Diso... Vestibular Schw... Space Motion Si... Motion Sickness | Traditional The... SWAN | 21 Years - 70 Years | Johns Hopkins University | |
| Vestibular Schwannoma Organoids | NCT05786144 | Vestibular Schw... | 18 Years - | Maastricht Radiation Oncology | ||
| Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma | NCT04196933 | Migraine Vestibular Migr... Vestibular Schw... Motion Sickness Dizziness Vestibular Diso... | Temporal Bindin... Temporal Bindin... Temporal Bindin... Chronic Motion-... | 8 Years - 80 Years | Massachusetts Eye and Ear Infirmary | |
| Auditory Nerve Test System During Vestibular Schwannoma Resection | NCT04241679 | Vestibular Schw... Acoustic Neurom... Sensorineural H... Asymmetric Sens... Cochlear Nerve ... Cochlear Nerve ... Skull Base Neop... Auditory; Nerve | Auditory Nerve ... | 12 Years - | Washington University School of Medicine | |
| Role of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery | NCT03638310 | Vestibular Schw... Vestibular Func... | intratympanic a... microsurgical r... | 18 Years - | Charles University, Czech Republic | |
| Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma | NCT01345136 | Neurofibromatos... Neuroma, Acoust... | RAD001, everoli... | 16 Years - 65 Years | Jonsson Comprehensive Cancer Center | |
| Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 | NCT04351373 | Vestibular Schw... | Fluorescein Sod... YELLOW560 filte... | 18 Years - | Mayo Clinic | |
| MR Fingerprinting for Vestibular Schwannomas | NCT04851925 | Vestibular Schw... | MR Fingerprinti... | 18 Years - 90 Years | Medical University of Vienna | |
| Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study | NCT01938677 | Vestibular Schw... | Initial Gamma k... | 18 Years - 70 Years | Karolinska Institutet | |
| CI Following VS Removal or Labyrinthectomy | NCT03795675 | Vestibular Schw... Meniere Disease | Cochlear Implan... | 18 Years - 70 Years | Ohio State University | |
| Concentration and Activity of Lapatinib in Vestibular Schwannomas | NCT00863122 | Vestibular Schw... NF2 Neurofibromatos... Acoustic Neurom... Auditory Tumor | lapatinib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Concentration and Activity of Lapatinib in Vestibular Schwannomas | NCT00863122 | Vestibular Schw... NF2 Neurofibromatos... Acoustic Neurom... Auditory Tumor | lapatinib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | NCT00973739 | Neurofibromatos... Vestibular Schw... | Lapatinib | 4 Years - 80 Years | NYU Langone Health | |
| Nimodipine in Vestibular Schwanommas | NCT04801953 | Vestibular Schw... | NiMODipine Inje... Placebo | 18 Years - 90 Years | Medical University of Vienna | |
| Concentration and Activity of Lapatinib in Vestibular Schwannomas | NCT00863122 | Vestibular Schw... NF2 Neurofibromatos... Acoustic Neurom... Auditory Tumor | lapatinib | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | NCT00973739 | Neurofibromatos... Vestibular Schw... | Lapatinib | 4 Years - 80 Years | NYU Langone Health | |
| Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function | NCT02415257 | Vestibular Schw... | Gentamicin | 18 Years - | Lund University | |
| Vestibular Outcomes in Vestibular Schwannoma | NCT03346889 | Vestibular Schw... | - | Haukeland University Hospital | ||
| Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) | NCT04374305 | Neurofibromatos... Vestibular Schw... Non-vestibular ... Meningioma Ependymoma | Brigatinib Neratinib | 12 Years - | Massachusetts General Hospital | |
| Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas | NCT05702749 | Vestibular Schw... | Microsurgical r... Stereotactic ra... PREHAB | 18 Years - | Medical College of Wisconsin | |
| Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma | NCT04859335 | Vestibular Schw... | gammaknife radi... | 18 Years - 65 Years | University Hospital, Toulouse | |
| Vestibular Schwannoma and Psychological Factors | NCT01743248 | Vestibular Schw... | 18 Years - 75 Years | Central Hospital, Nancy, France | ||
| WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data | NCT03210285 | Neurofibromatos... Vestibular Schw... Acoustic Neurom... | Whole exome seq... | 1 Day - 99 Years | University Hospital Tuebingen | |
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital | |
| Stereotactic Radiation in Vestibular Schwannoma | NCT01449604 | Vestibular Schw... | stereotactic ra... stereotactic ra... | 18 Years - 80 Years | Ramathibodi Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
